Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples